Cognitive effects of anesthetics and dopamine transport
麻醉药和多巴胺转运的认知影响
基本信息
- 批准号:6472109
- 负责人:
- 金额:$ 19.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-01 至 2004-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Description (provided by applicant): This grant is being submitted in response
to the program announcement, PA-96-026, "Molecular Pharmacology of Anesthetic
Action." The announcement states (in part) ." . .it has been difficult to
assign a direct correlation between molecular events that are influenced by
anesthetics and the physiological effects that subsequently occur." In the
preliminary data section, we present evidence of molecular interaction between
volatile anesthetics and the dopamine transporter (DAT). Our model is:
Initially, there is normal trafficking between expressed and cytoplasmic (DAT).
At induction of anesthesia, some anesthetic binds directly to the DAT and some
activates protein kinase C (PKC) causing some internalization of DAT. The
extracellular concentration of DA increases because fewer expressed DAT result
in less reuptake of DA. Continued release of DA is inhibited by a feedback
mechanism signaled from extracellular DA. During prolonged anesthesia, the
extracellular DA is metabolized, which decreases its concentration while
increasing the concentration of its metabolites. After cessation of anesthesia,
the anesthetic first clears from the body allowing the expressed DAT to
function and PKC to return to the inactive state. Then, DA concentration begins
to recover. After the system has nearly recovered, the DAT and extracellular DA
concentrations return to normal but additional DA must be synthesized to
replenish that lost to metabolism. Cognitive ability normalizes after all
subsystems return to baseline values. We propose to test this model with a
series of in vitro, rat, non-human primate and human studies and to determine
the physiological significance of these changes as they relate to cognitive
performance in humans through 3 specific aims: Specific Aim 1: Analyze the
DAT-anesthetic interaction at the cellular and sub-cellular level. We
hypothesize that DAT-anesthetic interaction will be significant at clinically
relevant concentrations for certain anesthetics and, we expect to see reduced
[18F]FECNT binding and [3H]dopamine uptake following anesthetic administration
due to trasnporter internalization. Specific Aim 2: Characterize the
DAT-anesthetic interaction in intact living tissue. We expect to confirm DAT
internalization and observe an initial increase in extracellular DA followed by
decreased DA and increased metabolites indicating decreased functioning of the
DAT. Results of these experiments in comparison with aim 1 will determine if
interaction with other neural systems is important. They will also provide a
direct calibration for interpreting the PET results in aim 3. Specific Aim 3:
Measure the duration of decreased [18F]FECNT binding potential following
anesthesia in humans and correlate with cognitive functioning. Using the
results from aims 1 and 2, this PET experiment will give information about DAT
expression in humans following anesthesia. We expect the time course to
normalization of the binding potential and cognitive performance to correlate
well.
说明(由申请人提供):本赠款是为了回应
PA-96-026,“麻醉剂的分子药理学”
行动上”声明说(部分)。" . .很难
在受影响的分子事件之间分配直接相关性
麻醉剂和随后发生的生理效应。“在
初步数据部分,我们提出的证据分子之间的相互作用
挥发性麻醉剂和多巴胺转运蛋白(DAT)。我们的模型是:
最初,在表达和细胞质(DAT)之间存在正常运输。
在麻醉诱导时,一些麻醉剂直接与DAT结合,而一些麻醉剂直接与DAT结合。
激活蛋白激酶C(PKC),引起DAT的一些内化。
细胞外DA浓度增加,因为较少表达的DAT导致
DA的持续释放被反馈抑制,
在长时间的麻醉过程中,
细胞外DA被代谢,降低其浓度,
增加其代谢物的浓度。停止麻醉后,
麻醉剂首先从体内清除,使表达的DAT
函数和PKC返回到非活动状态。然后,DA浓度开始
恢复在系统几乎恢复后,DAT和细胞外DA
浓度恢复正常,但必须合成额外的DA,
补充新陈代谢所损失的能量。认知能力最终恢复正常
子系统恢复到基线值。我们建议用一个
一系列体外、大鼠、非人灵长类动物和人类研究,并确定
这些变化的生理意义,因为它们涉及认知
通过3个具体目标在人类中的性能:具体目标1:分析
细胞和亚细胞水平的DAT-麻醉剂相互作用。我们
假设DAT-麻醉剂相互作用在临床上是显著
某些麻醉剂的相关浓度,我们希望看到减少
麻醉剂给药后的[18F]FECNT结合和[3 H]多巴胺摄取
这是由于转运体的内化。具体目标2:
完整活组织中的DAT-麻醉剂相互作用。我们希望确认DAT
内化并观察细胞外DA的初始增加,
DA减少和代谢物增加,这表明
DAT。与目标1相比,这些实验的结果将确定
与其他神经系统的互动是很重要的。他们还将提供一个
直接校准,用于解释目标3中的PET结果。具体目标3:
测量[18F]FECNT结合电位降低的持续时间,
与认知功能有关。使用
从目标1和2的结果,这个PET实验将提供有关DAT的信息
在人体麻醉后的表达。我们希望时间进程
结合潜力和认知表现的正常化,
好.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John R Votaw其他文献
John R Votaw的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John R Votaw', 18)}}的其他基金
Core C: Biostatistics, Modeling, and Data Management
核心 C:生物统计学、建模和数据管理
- 批准号:
7287008 - 财政年份:2007
- 资助金额:
$ 19.62万 - 项目类别:
Cognitive effects of anesthetics and dopamine transport
麻醉药和多巴胺转运的认知影响
- 批准号:
6647711 - 财政年份:2002
- 资助金额:
$ 19.62万 - 项目类别:
相似海外基金
Investigation of the mechanism of recovery effect of anesthetics on endothelial glycocalyx damage
麻醉药对内皮糖萼损伤恢复作用的机制探讨
- 批准号:
23K08341 - 财政年份:2023
- 资助金额:
$ 19.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of a Novel Functional Mechanism of Intravenous Anesthetics Based on the Membrane Lipid Theory and Its Application to Clinical Practice
基于膜脂理论的静脉麻醉药新作用机制的阐明及其在临床实践中的应用
- 批准号:
23K06361 - 财政年份:2023
- 资助金额:
$ 19.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics
产后接触 GABA 激动剂和麻醉剂会扰乱大脑奖励系统
- 批准号:
10657509 - 财政年份:2022
- 资助金额:
$ 19.62万 - 项目类别:
Electrophysiological analysis of proarrhythmic properties of volatile anesthetics using an originally developed arrhythmogenic model
使用最初开发的致心律失常模型对挥发性麻醉药的致心律失常特性进行电生理分析
- 批准号:
22K09032 - 财政年份:2022
- 资助金额:
$ 19.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modification of the intercellular network of immune cells in tumor microenvironment by sedatives and anesthetics.
通过镇静剂和麻醉剂改变肿瘤微环境中免疫细胞的细胞间网络。
- 批准号:
22K09083 - 财政年份:2022
- 资助金额:
$ 19.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of astrocytes in emergence from volatile anesthetics
星形胶质细胞在挥发性麻醉剂苏醒中的作用
- 批准号:
10340339 - 财政年份:2022
- 资助金额:
$ 19.62万 - 项目类别:
Mechanisms and blood-based biomarkers of intergenerational neurobehavioral effects of general anesthetics
全身麻醉药代际神经行为效应的机制和血液生物标志物
- 批准号:
10538703 - 财政年份:2022
- 资助金额:
$ 19.62万 - 项目类别:
Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics
产后接触 GABA 激动剂和麻醉剂会扰乱大脑奖励系统
- 批准号:
10440005 - 财政年份:2022
- 资助金额:
$ 19.62万 - 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
- 批准号:
10870632 - 财政年份:2022
- 资助金额:
$ 19.62万 - 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
- 批准号:
10671023 - 财政年份:2022
- 资助金额:
$ 19.62万 - 项目类别: